Friday, December 2, 2022

Brief Blog: New & Evolving Presentations for Subscription-only Papers

 We typically divide the world into subscription-only publications and open-access ones.   Lately I've seen some innovations.   At both J Amer Coll Radiol and Ann Intern Med, I've started seeing editorially-produced 'Visual Abstracts' on selected papers in each issue.

Here's a paper in Critical Reviews in Oncology/Hematology which is of high interest in itself, but also shows some editorial innovations.  The title is, "The Evolving Landscape of Anatomic Pathology," by Pisapia et al., and basic makes the point that anatomic pathology matters, but that anatomic pathology in itself is rapidly becoming a dinosaur, and any modern anatomic pathologist is equally fluent in discussing and incorporating molecular plus anatomic findings.   It's subscription, but the "innovations" include an editor's Visual Abstract, and an online format that includes the full abstract (of course), plus, a long extract from the Introduction, and then,  select snippets from other parts of the publication.   This gives you a window into the publication - like browsing a hardcover book in a bookstore - that I haven't seen before.

Find it here:

Graphical Abstract:


I suspect that Visual Abstracts will vary widely in their actual impact and usability, that some will be very insightful and others just a confusing jumble of some illustrative material and an arrow or two.

Pisapia et al. Abstract

Anatomic pathology has changed dramatically in recent years. Although the microscopic assessment of tissues and cells is and will remain the mainstay of cancer diagnosis molecular profiling has become equally relevant. Thus, to stay abreast of the evolving landscape of today’s anatomic pathology, modern pathologists must be able to master the intricate world of predictive molecular pathology. To this aim, pathologists have had to acquire additional knowledge to bridge the gap between clinicians and molecular biologists. This new role is particularly important, as cases are now collegially discussed in molecular tumor boards (MTBs). Moreover, as opposed to traditional pathologists, modern pathologists have also adamantly embraced innovation while keeping a constant eye on tradition. In this article, we depict the highlights and shadows of the upcoming “Anatomic Pathology 2.0” by placing particular emphasis on the pathologist’s growing role in the management of cancer patients.